Skip Navigation

Treatment of Localized Transitional Cell Cancer of the Renal Pelvis and Ureter

Treatment of localized transitional cell cancer of the renal pelvis and ureter may include:

  • surgery (nephroureterectomy or segmental resection of ureter)
  • a clinical trial of fulguration
  • a clinical trial of laser surgery
  • a clinical trial of segmental resection of the renal pelvis
  • a clinical trial of regional chemotherapy or regional immunotherapy

To learn more about these treatments, see the Treatment Option Overview.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from Adapted from the National Cancer Institute's Physician Data Query (PDQ®) Cancer Information Summaries on www.cancer.gov.